[ET Net News Agency, 30 March 2020] CSPC Pharmaceutical Group Limited (01093) said its
profit attributable to shareholders was RMB3.71 billion for the year ended 31 December
2019, a year-on-year increase of 20.6%. The basic earnings per share were RMB59.65 cents.
A final dividend of HK20 cents will be distributed.
The total revenue was RMB22.1 billion, a year-on-year increase of 24.8%. (RC)